Professional Profile

Whether it’s for an academic institution with programs in biomedical engineering, clinical departments, medical device designers, or a patent office specializing in medical devices, our company has the extensive knowledge and expertise to tackle any medical device issue. From providing expert opinions on medical device liability issues; providing advice to properly ensure a smooth FDA approval process, and protecting your intellectual property, we are the consulting firm you should turn to first.

Dr. George Yanulis, M.E., M.S., D.Eng.- is the CEO and Principal Engineer for Medical Device Consulting LLC. He is an experienced Medical Device Research & Development Engineer with over twenty years of experience with all types of cardiac implantable systems to include vascular stents, cardiac pacing devices, ventricular assist devices, cardiac echocardiography and electrophysiology devices, physiological monitoring equipment; surgical devices; neurological therapy devices; and medical imaging systems. Dr. Yanulis is affiliated both with a start-up medical imaging company, Integral ElectroMagnetronic Technologies, as their Scientific Director and with GAMY Technologies as their Clinical Engineering Director and FDA medical device expert.

Dr. Yanulis brings a solid understanding of all aspects of field research, pre-clinical trial implementation, product development, and FDA protocols and offers unique and valuable insights into product development from a variety of key perspectives. Some of his previous research work conducted at the Cleveland Clinic involved conscious testing of animal subjects for research studies related to the use and effectiveness of a novel cardiac pacing device. In this previous role in the Departments of Cardiovascular Medicine and Biomedical Engineering at the Cleveland Clinic’s Lerner Research Institute, he provided preoperative and postoperative monitoring and care of test subjects. He also monitored and collected data during the surgical implantation of pacing devices and is working to determine the efficacy of a new stimulation paradigm as sustained therapy for chronic heart failure with or without atrial fibrillation.